Health Care & Life Sciences » Pharmaceuticals | Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.78
Market Cap
$22.09 M
Shares Outstanding
22.08 M
Public Float
8.08 M

Profile

Address
11 Commerce Drive
Cranford New Jersey 07016
United States
Employees -
Website http://www.citiuspharma.com
Updated 07/08/2019
Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. Its products include Mino-Lok and hydrocortisone-lidocaine. The company was founded on September 09, 2010 and is headquartered in Cranford, NJ.

Financials

View All
Created with Highcharts 5.0.14Citius Pharmaceuticals Inc.Net Income. Fiscal year is October-September. All values USD Thousands.9819812 9022 9028 2958 29510 38510 38512 53612 5362014201520162017201802.5k5k7.5k10k12.5k15k

Leonard L. Mazur
Executive Chairman & Secretary
Myron Z. Holubiak
President, Chief Executive Officer & Director